GlassScriptPhysician profile
Jennifer M Baxter
NPI 1922157734
$1,692.96
in general payments reported to CMS, 2019-2025
23 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $547 · 2023: $322 · 2024: $355 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $470.33 | 2021-2023 | |
| Organon LLC | $200.36 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $117.49 | 2023-2025 | Aptima |
| Merck Sharp & Dohme LLC | $103.31 | 2021-2025 | Gardasil, Gardasil 9 |
| Exeltis, USA INC. | $95.15 | 2022-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $83.64 | 2022-2023 | |
| Astellas Pharma US INC | $79.72 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $71.51 | 2023-2025 | |
| Agile Therapeutics, INC. | $70.74 | 2021-2022 | |
| Coopersurgical, INC. | $63.16 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $62.61 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $50.71 | 2021 | |
| Pfizer INC. | $37.03 | 2022-2024 | |
| Exact Sciences Corporation | $32.41 | 2023 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $24.74 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.14 | 2025 | Bulkamid |
| Smith+Nephew, INC. | $18.25 | 2025 | "Acticoat 4"" X 4""", Pico 7 |
| Gynesonics, INC. | $17.66 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Biogen, INC. | $17.06 | 2024 | Zurzuvae |
| Sanofi Pasteur INC. | $17.06 | 2024 | |
| Scynexis, INC. | $15.28 | 2022 | |
| Evofem Biosciences, INC. | $13.34 | 2022 | |
| Avion Pharmaceuticals | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.